A carregar...

Venetoclax-based Therapies for Acute Myeloid Leukemia

The prognosis of adult acute myeloid leukemia (AML) remains poor, with the long-term survival rate less than 50%. However, the current paradigms of treatment are changing through a better understanding of the disease genetics and pathophysiology. Since 2017, eight new drugs have been approved by the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Best Pract Res Clin Haematol
Main Authors: Guerra, Veronica A., DiNardo, Courtney, Konopleva, Marina
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581210/
https://ncbi.nlm.nih.gov/pubmed/31203996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2019.05.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!